This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of biologically active molecules. Its structure, featuring both amino and carboxylate groups, makes it a versatile building block in organic synthesis. It is often employed in the preparation of pyrrolidine derivatives, which are key components in drugs targeting neurological disorders, such as Alzheimer's disease and Parkinson's disease. Additionally, it serves as a precursor in the creation of ligands for asymmetric catalysis, enhancing the efficiency of chiral synthesis in drug manufacturing. Its stability and reactivity also make it suitable for use in combinatorial chemistry for high-throughput screening of potential drug candidates.